期刊文献+

基质金属蛋白酶-9、Ⅳ型胶原、CD34在卵巢上皮性肿瘤中的表达及意义 被引量:1

Expressions of matrix metalloproteinase-9,IV collagen and CD34 in epithelial ovarian tumor and its significance
原文传递
导出
摘要 目的 探讨基质金属蛋白酶(MMP)-9、Ⅳ型胶原、CD34在卵巢上皮性肿瘤中的表达及意义.方法 卵巢上皮性肿瘤患者82例,其中卵巢恶性上皮性肿瘤48例,卵巢交界性上皮性肿瘤23例,卵巢良性上皮性肿瘤11例.采用免疫组化染色方法,检测MMP-9、Ⅳ型胶原和CD34在肿瘤组织中的表达情况.结果 MMP-9的表达强度随肿瘤恶性程度增加而增强(F=39.306,P〈0.01).CD34的表达亦随肿瘤恶性程度增加而增强[卵巢良性上皮性肿瘤为(17.18±5.64)%,卵巢交界性上皮性肿瘤为(29.76±7.18)%,高分化卵巢恶性上皮性肿瘤为(57.20±8.55)%,中分化卵巢恶性上皮性肿瘤为(71.20±8.48)%,低分化卵巢恶性上皮性肿瘤为(90.38 ±20.03)%](F=100.072,P〈0.01).Ⅳ型胶原在卵巢恶性上皮性肿瘤中的表达强度低于在卵巢交界性上皮性肿瘤和卵巢良性上皮性肿瘤中的表达强度(F=11.554,P〈0.01). MMP-9表达与CD34表达、Ⅳ型胶原缺失表达均呈正相关(r值分别为0.802和0.796,P〈0.01).结论 MMP-9、CD34表达随着卵巢上皮性肿瘤恶性程度的增加而增强,Ⅳ型胶原的表达在卵巢恶性上皮性肿瘤中明显减少.MMP-9表达与CD34表达、Ⅳ型胶原缺失表达呈正相关.通过联合检测MMP-9、CD34、Ⅳ型胶原在卵巢上皮性肿瘤中的表达对判断其恶性程度具有重要的临床意义. Objective To explore the expression and significance of matrix metalloproteinase (MMP)-9, IV collagen and CD34 in epithelial ovarian tumor. Methods Eighty-two patients with epithelial ovarian tumor, among them,there were 48 malignant epithelial ovarian carcinomas, 23 borderline epithelial ovarian tumors and 11 benign epithelial ovarian tumors. The expression of MMP-9, IV collagen and CD34 were detected by immunohistochemistry. Results The expression of MMP-9 was strongly linked to the degree of malignant ovarian carcinomas (F= 39.306,P〈 0.01). The expression of CD34 was also strongly linked to the degree of malignant ovarian carcinomas [benign epithelial ovarian tumors was (17.18±5.64)%,borderline epithelial ovarian tumors was (29.76±7.18)%,well-differentiated malignant epithelial ovarian carcinomas was (57.20±8.55)%,moderately-differentiated malignant epithelial ovarian carcinomas was (71.20±8.48)%, poorly-differentiated malignant epithelial ovarian carcinomas was(90.38±20.03)%](F= 100.072, P 〈 0.01). The expression of IV collagen in malignant epithelial ovarian carcinomas was different from that in borderline epithelial ovarian tumors and benign epithelial ovarian tumors (F = 11.554,P〈0.0l). The expression of MMP-9 was positive correlation with the loss expression of IV collagen and the expression of CD34 (r=0.796,0.802,P〈 0.01).Conclusions The positive expression of MMP-9,CD34 and the negative expression of IV collagen are obviously relevant to degree of malignant ovarian carcinomas.The combined testing on expression of MMP-9,CD34, IV collagen on ovarian carcinomas is significant to decide degree of malignant ovarian carcinomas and evaluate future development.
出处 《中国医师进修杂志》 2010年第15期1-4,共4页 Chinese Journal of Postgraduates of Medicine
关键词 卵巢肿瘤 基质金属蛋白酶9 胶原Ⅳ型 抗原 CD34 Ovarian neoplasms Matrix metalloproteinase 9 Collagen type IV Antigens,CD34
  • 相关文献

参考文献10

  • 1Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2002,2(3 ): 161-174.
  • 2Sehuller HM, Porter B, Rieehert A. Beta-adrenergie modulation of NNK-indueod lung carcinogenesis in harnstem. J Cancer Res Clin Oneol, 2000,126( 11 ) : 624-630.
  • 3Lang K, Drell TL 4th, Lindecke A, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer,2004,112(2):231- 238.
  • 4Murthi P, Barker G, Nowell CJ,et al. Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression. Gynecol Oncol, 2004,92( 1 ) : 80-88.
  • 5Demeter A,Szirmai K, Ol a h J, et al. Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer. Orv Hetil,2004,145(31 ) : 1617-1624.
  • 6Kim TJ ; Rho SB, Choi YL, et al. High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis. Hum Pathol,2006,37(7):906-913.
  • 7吴畏,何剪太,阮景德,王荣兵,张阳德.MMP-2、MMP-9与Ⅳ型胶原在大肠癌中的表达及其相关性研究[J].细胞与分子免疫学杂志,2008,24(9):908-909. 被引量:13
  • 8Weidner N, Gasparini G. Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients. Breast Cancer Res Treat, 1994,29 ( 1 ) : 97-107.
  • 9Raspollini MR,Amunni G, Villanucci A,et al. Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma. Int J Gynecol Cancer, 2004,14(5) : 815-823.
  • 10Sonmezer M,G u ngnr M,Ensari A,et al. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer, in association with transforming growth factor beta and vascular endothelial growth factor. Int J Gynecol Cancer, 2004,14( 1 ) : 82-88.

二级参考文献7

  • 1Martinez HA, Amenta PS. The basement membrane in pathology[ J]. Lab Invest, 1983,48(6) : 656 -677.
  • 2Davidson B, Givant-Horwitz V, Lazarovici P, et al. Matrix metalloproteinases (MMP), EMMPRIN (extraceUular matrix metalloproteinase inducer) and mitogen-activated proteinkinases (MAPK) : co-expression in metastatic serous ovarian carcinoma [ J ]. Clin Exp Metastasis, 2003, 20(7) : 621 -631.
  • 3Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis[J]. Cancer, 1997, 80(8 Suppl) : 1529-1537.
  • 4成军.细胞外基质的分子生物学与临床疾病[M].北京:北京医科大学出版社,1996:9.
  • 5Westermarck J, Kahari VM. Regulation of matrix metaUoproteinase expression in tumor invasion[J]. FASEB, 1999, 13(3) : 781 -792.
  • 6Moran A, Iniesta P, Garcia-Aranda C, et al. Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer[ J]. Oncol Rep, 2005, 13(1): 115-120.
  • 7Zucker S, Vacirca J. Role of matrix metalloproteinases in colorectal cancer[ J]. Cancer Metastasis Rev, 2004, 23 ( 1 - 2) : 101 - 117.

共引文献12

同被引文献9

  • 1丁国芳,李继承,徐银峰,杨最素.前列腺癌组织TGF-β1、CD31表达及与PSA、TNM分期的相关性研究[J].中华泌尿外科杂志,2005,26(5):315-317. 被引量:13
  • 2申永璋,林霞,宋世德,滕兆礼,王纪三,苏磊,丁波.前列腺癌组织中血管生成与细胞外基质的相关性[J].山东医药,2006,46(20):13-15. 被引量:1
  • 3Garzetti GG, Ciavattini A, Luearini G, et al. Expression of vascular endothelial growth factor related to 72 kilodalton metalloproteinase immunostaining in patients with serous varian tumors .Cancer ,1999,85(10):2219-2225.
  • 4Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med, 1991,324( 1 ) : 1-8.
  • 5Justulin LA Jr, Della-Coleta HH, Taboga SR, et al. Matrix metalloproteinase (MMP)-2 and MMP-9 activity and localization during ventral prostate atrophy and regrowth. Int J Androl, 2010,33(5) :696-708.
  • 6Keller ET. The role of osteoclastic activity in prostate cancer skeletal metastases. Drugs Today ( Bare ), 2002,38 ( 2 ) : 91-102.
  • 7Brewer CA, Setterdahl J J, Li M J, et al. Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol,2000,96(2):224-228.
  • 8Kaygusuz G, Tulunay O, Baltaci S, et al. Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue. Int Urol Nephrol, 2007,39(3 ) : 841-850.
  • 9Littlepage LE, Sternlicht MD, Rougier N, et al. Matrix metallopro- teinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res, 2010,70(6) :2224-2234.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部